3 Year Absolute Returns
59.46% ↑
NAV (₹) on 09 Sep 2026
32.18
1 Day NAV Change
0.08%
Risk Level
Very High Risk
Rating
-
Tata India Pharma & HealthCare Fund is a Equity mutual fund categorized under Sector, offered by Tata Asset Management Ltd.. Launched on 04 Dec 2015, investors can start with a minimum SIP of ₹100 or ... Read more
AUM
₹ 1,541.42 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 62.71% |
| Hospitals & Medical Services | 28.90% |
| Agro Chemicals/Pesticides | 4.85% |
| Personal Care | 1.15% |
| Chemicals - Organic - Others | 0.97% |
| Cash | 0.61% |
| Chemicals - Speciality | 0.55% |
| Treps/Reverse Repo | 0.26% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | 8.59% | ₹ 132.40 | Pharmaceuticals |
| DIVI LABORATORIES LTD | 6.36% | ₹ 98 | Pharmaceuticals |
| HEALTHCARE GLOBAL ENTERPRISES LTD | 5.85% | ₹ 90.21 | Hospitals & Medical Services |
| ABBOTT INDIA LTD | 5.63% | ₹ 86.82 | Pharmaceuticals |
| RAINBOW CHILDRENS MEDICARE LTD | 4.90% | ₹ 75.52 | Hospitals & Medical Services |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD | 4.66% | ₹ 71.87 | Pharmaceuticals |
| CIPLA LTD | 4.53% | ₹ 69.81 | Pharmaceuticals |
| DR REDDYS LABORATORIES LTD | 4.25% | ₹ 65.48 | Pharmaceuticals |
| MAX HEALTHCARE INSTITUTE LTD | 4.07% | ₹ 62.78 | Hospitals & Medical Services |
| APOLLO HOSPITALS ENTERPRISE LTD | 3.90% | ₹ 60.18 | Hospitals & Medical Services |
| BAYER CROPSCIENCE LTD | 3.26% | ₹ 50.31 | Agro Chemicals/Pesticides |
| FORTIS HEALTHCARE LTD | 3.12% | ₹ 48.13 | Hospitals & Medical Services |
| PFIZER LTD | 3.06% | ₹ 47.12 | Pharmaceuticals |
| MANKIND PHARMA LTD | 3.02% | ₹ 46.53 | Pharmaceuticals |
| SYNGENE INTERNATIONAL LTD | 2.95% | ₹ 45.53 | Pharmaceuticals |
| SAI LIFE SCIENCES LTD | 2.89% | ₹ 44.52 | Pharmaceuticals |
| LUPIN LTD | 2.64% | ₹ 40.76 | Pharmaceuticals |
| ALKEM LABORATORIES LTD | 2.58% | ₹ 39.72 | Pharmaceuticals |
| PROCTER & GAMBLE HEALTH LTD | 2.42% | ₹ 37.25 | Pharmaceuticals |
| FDC LTD | 2.39% | ₹ 36.84 | Pharmaceuticals |
| DR. LAL PATH LABS LTD | 2.17% | ₹ 33.50 | Hospitals & Medical Services |
| GLOBAL HEALTH LTD | 2.13% | ₹ 32.88 | Hospitals & Medical Services |
| CONCORD BIOTECH LTD | 1.91% | ₹ 29.46 | Pharmaceuticals |
| SUMITOMO CHEMICAL INDIA LTD | 1.59% | ₹ 24.49 | Agro Chemicals/Pesticides |
| AJANTA PHARMA LTD | 1.53% | ₹ 23.58 | Pharmaceuticals |
| NEULAND LABORATORIES LTD | 1.25% | ₹ 19.30 | Pharmaceuticals |
| GILLETTE INDIA LTD | 1.15% | ₹ 17.76 | Personal Care |
| METROPOLIS HEALTHCARE LTD | 1.12% | ₹ 17.32 | Hospitals & Medical Services |
| BASF INDIA LTD | 0.97% | ₹ 14.90 | Chemicals - Organic - Others |
| MANIPAL HEALTH ENTERPRISES LTD | 0.97% | ₹ 14.96 | Hospitals & Medical Services |
| JUBILANT PHARMOVA LTD | 0.83% | ₹ 12.73 | Pharmaceuticals |
| DR. AGARWALS HEALTH CARE LTD | 0.67% | ₹ 10.29 | Hospitals & Medical Services |
| CASH / NET CURRENT ASSET | 0.61% | ₹ 9.27 | Others |
| SANOFI CONSUMER HEALTHCARE INDIA LTD | 0.55% | ₹ 8.47 | Chemicals - Speciality |
| BIOCON LTD | 0.52% | ₹ 7.98 | Pharmaceuticals |
| ZIM LABORATORIES LTD | 0.46% | ₹ 7.13 | Pharmaceuticals |
| TREPS | 0.26% | ₹ 3.97 | Others |
| SANOFI INDIA LTD | 0.23% | ₹ 3.53 | Pharmaceuticals |
| ANTHEM BIOSCIENCES LTD | 0.01% | ₹ 0.11 | Pharmaceuticals |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 6.57% | 4.74% | 2.22% | 16.83% |
| Category returns | 6.09% | 6.62% | 4.80% | 21.03% |
The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹38.32 | 124.33% | 316.88% | 0.00% | ₹1,128 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹38.32 | 124.33% | 316.88% | 0.00% | ₹1,128 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹38.32 | 124.33% | 316.88% | 0.00% | ₹1,128 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹35.78 | 121.33% | 300.01% | 0.00% | ₹1,128 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹35.78 | 121.33% | 300.01% | 0.00% | ₹1,128 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹35.78 | 121.33% | 300.01% | 0.00% | ₹1,128 | 2.53% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹32.18 | 35.80% | 157.18% | 0.00% | ₹11,478 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹32.18 | 35.80% | 157.18% | 0.00% | ₹11,478 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹32.18 | 35.80% | 157.18% | 0.00% | ₹11,478 | 0.90% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹31.04 | 34.47% | 148.89% | 0.00% | ₹11,478 | 1.79% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Tata India Pharma & HealthCare Fund - Direct Plan
Sector
Direct
|
₹39.56 | 10.48% | 73.25% | 99.36% | ₹1,541 | 0.97% |
Very High
|
|
Tata India Pharma & HealthCare Fund - Direct Plan
Sector
Direct
|
₹38.28 | 6.88% | 67.62% | 92.88% | ₹1,541 | 0.97% |
Very High
|
|
Tata India Pharma & HealthCare Fund - Direct Plan
Sector
Direct
|
₹38.28 | 6.88% | 67.62% | 92.88% | ₹1,541 | 0.97% |
Very High
|
|
Tata India Pharma & HealthCare Fund
Sector
Regular
|
₹33.46 | 8.91% | 65.81% | 85.15% | ₹1,541 | 2.28% |
Very High
|
|
Tata India Pharma & HealthCare Fund
Sector
Regular
|
₹32.18 | 4.74% | 59.46% | 78.06% | ₹1,541 | 2.28% |
Very High
|
|
Tata Resources & Energy Fund - Direct Plan
Sector
Direct
|
₹58.65 | 11.09% | 54.65% | 83.92% | ₹1,421 | 0.84% |
Very High
|
|
Tata Mid Cap Fund - Direct Plan
Diversified
Direct
|
₹532.50 | 8.74% | 50.91% | 104.08% | ₹6,056 | 0.84% |
Very High
|
|
Tata Dividend Yield Fund - Direct Plan
Diversified
Direct
|
₹21.67 | 13.56% | 50.71% | 93.97% | ₹1,122 | 0.76% |
Very High
|
|
Tata Dividend Yield Fund - Direct Plan
Diversified
Direct
|
₹21.67 | 13.56% | 50.71% | 93.97% | ₹1,122 | 0.76% |
Very High
|
|
Tata Dividend Yield Fund - Direct Plan
Diversified
Direct
|
₹21.67 | 13.56% | 50.71% | 93.97% | ₹1,122 | 0.76% |
Very High
|
What is the current NAV of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?
What is the fund size (AUM) of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?
What are the historical returns of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?
What is the risk level of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?
What is the minimum investment amount for Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article